My inclination is to go through to FDA approval with fewer shares
I would suggest that the FDA is much more likely to approve based upon scientific merits. Much less risk through the FDA than through the EMEA for a trangenic animal. I had avoided the stock precisely for this reason, but now if it can go low enough ... .